Ordering
Available Variants10 mg
CHA.50984-10mg
Price
€95.88
Available – Dispatch in 14 days
50 mg
CHA.50984-50mg
Price
€400.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.50984-10mg | €95.88 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.50984-50mg | €400.80 |
≥98% (HPLC), GABAA agonist, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C6H8ClNS · HCl |
|---|---|
| CAS Number | 6001-74-7 |
| Molecular Weight | 198.11 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329774745 |
| NACRES | NA.77 |
| MDL number | MFCD00673948 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| pictograms |
GHS05
GHS07
  GHS05,GHS07
|
|---|---|
| signalword | Danger |
| hcodes | H302,H317,H318 |
| pcodes | P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 + P310 |
| Hazard Classifications | Acute Tox. 4 Oral - Eye Dam. 1 - Skin Sens. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
Technical Overview & Applications Use-case context
Chlormethiazole hydrochloride, with a CAS number of 533-45-9, is a sedative and anxiolytic medication that has been utilized in the management of anxiety disorders and insomnia. It functions by modulating the activity of the neurotransmitter gamma-aminobutyric acid, thereby exerting a calming effect on the central nervous system. The compounds mechanism of action involves the potentiation of GABAs inhibitory effects, which leads to a decrease in neuronal excitability and a consequent reduction in anxiety and stress responses. Chlormethiazole hydrochloride has also been investigated for its potential in treating withdrawal symptoms associated with alcohol dependence, owing to its ability to alleviate the severity of these symptoms and facilitate a more comfortable detoxification process. Its pharmacological profile and therapeutic applications have been the subject of extensive research and clinical studies.
